Gains in employment status following antidepressant medication or cognitive therapy for depression

British Journal of Psychiatry

Volumn 206, Issue 4, 2015, Pages 332-338

  Fournier, Jay C ^a   DeRubeis, Robert J ^b   Amsterdam, Jay ^c   Shelton, Richard C ^d   Hollon, Steven D ^e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; LITHIUM; PAROXETINE; PLACEBO; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; EMPLOYMENT STATUS; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; DEPRESSIVE DISORDER, MAJOR; EMPLOYMENT; ODDS RATIO; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; EMPLOYMENT; FOLLOW-UP STUDIES; HUMANS; ODDS RATIO; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84928045456     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.133694     Document Type: Article

References (37)

1. rd edn). APA, 2010.
2. Cuijpers P, Hollon SD, van Straten A, Bockting C, Berking M, Andersson G. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open 2013; 3: e002542.
3. Warr P, Jackson P, Banks M. Unemployment and mental health: some British studies. J Soc Issues 1988; 44: 47-68.
4. Feather N. The Psychological Impact of Unemployment. Springer-Verlag, 1990.
5. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409-16.
6. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005; 62: 417-22.
7. th edn, text revised) (DSM-IV-TR). APA, 2000.
8. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR- Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). Biometrics Research, New York State Psychiatric Institute, 2001.
9. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
10. Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, et al. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998; 155: 1247-53.
11. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-IIR Personality Disorders (SCID-II, Version 1.0). American Psychiatric Press, 1990.
12. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH. Clinical management-imipramine/placebo administration manual: NIMH treatment of depression collaborative research program. Psychopharmacol Bull 1987; 23: 309-24.
13. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989; 46: 971-82.
14. Strunk DR, Brotman MA, DeRubeis RJ, Hollon SD. Therapist competence in cognitive therapy for depression: predicting subsequent symptom change. J Consult Clin Psychol 2010; 78: 429-37.
15. Keller MB, Lavori P, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, et al. The Longitudinal Interval Follow-up Evaluation. Arch Gen Psychiatry 1987; 44: 540-8.
16. Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761-8.
17. Murphy GE, Simons AD, Wetzel RD, Lustman PJ. Cognitive therapy and pharmacotherapy: singly and together in the treatment of depression. Arch Gen Psychiatry 1984; 41: 33.
18. Jacobson NS, Hollon SD. Cognitive-behavior therapy versus pharmacotherapy: now that the jury's returned its verdict, it's time to present the rest of the evidence. J Consult Clin Psychol 1996; 64: 74-80.
19. Timbie JW, Horvitz-Lennon M, Frank RG, Normand SLT. A meta-analysis of labor supply effects of interventions for major depressive disorder. Psychiatr Serv 2006; 57: 212-8.
20. Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ, McCulloch J, et al. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes. JAMA 2007; 298: 1401-11.
21. Clark DM, Layard R, Smithies R, Richards DA, Suckling R, Wright B. Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behav Res Ther 2009; 47: 910-20.
22. Proudfoot J, Guest D, Carson G, Gray J. Effect of cognitive-behavioural training on job-finding among long-term unemployed people. Lancet 1997; 350: 96-100.
23. Della-Posta C, Drummond PD. Cognitive behavioural therapy increases re-employment of job seeking worker's compensation clients. J Occup Rehabil 2006; 16 : 217-24.
24. Smith EG, Henry AD, Zhang J, Hooven F, Banks SM. Antidepressant adequacy and work status among medicaid enrollees with disabilities: a restriction-based, propensity score-adjusted analysis. Community Ment Health J 2009; 45: 333-40.
25. Dewa CS, Hoch JS, Lin E, Paterson M, Goering P. Pattern of antidepressant use and duration of depression-related absence from work. Br J Psychiatry 2003; 183: 507-13.
26. Waghorn G, Chant D. Receiving treatment, labor force activity, and work performance among people with psychiatric disorders: results from a population survey. J Occup Rehabil 2011; 21: 547-58.
27. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009; 77: 775-87.
28. Quilty LC, McBride C, Bagby RM. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression. Psychol Med 2008; 38: 1531-41.
29. DeRubeis RJ, Evans MD, Hollon SD, Garvey MJ, Grove WM, Tuason VB. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol 1990; 58: 862-9.
30. Strunk DR, DeRubeis RJ, Chiu AW, Alvarez J. Patients' competence in and performance of cognitive therapy skills: Relation to the reduction of relapse risk following treatment for depression. J Consult Clin Psychol 2007; 75: 523-30.
31. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. The Guilford Press, 1979.
32. Lagerveld SE, Blonk RW, Brenninkmeijer V, Wijngaards-de Meij L, Schaufeli WB. Work-focused treatment of common mental disorders and return to work: a comparative outcome study. J Occup Health Psychol 2012; 17: 220-34.
33. Venditti LN, Arcelus A, Birnbaum H, Greenberg P, Barr CE, Rowland C, et al. The impact of antidepressant use on social functioning: reboxetine versus fluoxetine. Int Clin Psychopharmacol 2000; 15: 279-89.
34. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA 2002; 287: 203-9.
35. Marcus SC, Olfson M. National trends in the treatment of depression from 1998 to 2007. Arch Gen Psychiatry 2010; 67: 1265-73.
36. Dobson KS, Hollon SD, Dimidjian S, Schmaling KB, Kohlenberg RJ, Gallop RJ, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 2008; 76 : 468-77.
37. Clark DM. Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: the IAPT experience. Int Rev Psychiatry 2011; 23: 375-84.